Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid

Transplant Proc. 1999 Nov;31(7A):75S-77S. doi: 10.1016/s0041-1345(99)00801-5.

Authors

J M Morales¹, A Andrés, E Morales, J C Herrero, A Cubas, M Praga, E Hernández, T Ortuño, B Dominguez-Gil, A Carreño, M Delgado, C Manzanares

Affiliation

¹ Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. jmorales@h120.es

PMID: 10576051
DOI: 10.1016/s0041-1345(99)00801-5

No abstract available

Publication types

Clinical Trial
Multicenter Study
Randomized Controlled Trial

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Adult
Drug Therapy, Combination
Europe
Female
Graft Rejection / epidemiology
Graft Rejection / prevention & control
Graft Survival*
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Kidney Transplantation / mortality
Kidney Transplantation / physiology
Male
Middle Aged
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / therapeutic use
Postoperative Complications / epidemiology
Spain
Survival Rate
Tacrolimus / therapeutic use*

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Mycophenolic Acid
Tacrolimus